EP
AURA icon

Essential Partners’s Aura Biosciences AURA Stock Holding History

Essential Partners’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$824 Sell
116
-431
-79% -$3.08K ﹤0.01% 2329
2026
Q1 		$3.66K Buy
+547
New +$3.14K ﹤0.01% 1727

Other funds holding AURA

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Essential Partners's AURA Position: Q2 2026 in Review

Essential Partners reduced its Aura Biosciences (AURA) stake by 79% in Q2 2026, selling an estimated $3.08K and leaving 116 shares worth $824. The position accounts for ﹤0.01% of the portfolio, ranked #2329.

Essential Partners first reported a position in AURA in Q1 2026 and has held it in 2 quarters since. The position peaked at $3.66K in Q1 2026. 147 funds tracked by Wall St. Rank hold AURA as of Q2 2026.

  • Essential Partners held 116 shares of Aura Biosciences worth $824 as of Q2 2026.
  • Essential Partners sold 431 Aura Biosciences shares in Q2 2026, an estimated $3.08K.
  • Aura Biosciences made up ﹤0.01% of Essential Partners's portfolio in Q2 2026, its #2329 holding.
  • Essential Partners first reported a position in Aura Biosciences in Q1 2026 and has held it in 2 quarters since.
  • Essential Partners's Aura Biosciences position peaked at $3.66K in Q1 2026.
  • 147 funds tracked by Wall St. Rank held Aura Biosciences as of Q2 2026.

Based on Essential Partners's 13F filing for Q2 2026, filed 10 Aug 2026.